336 related articles for article (PubMed ID: 16640812)
21. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
Rodríguez J; Conde E; Gutiérrez A; Arranz R; Gandarillas M; Leon A; Ojanguren J; Sureda A; Carrera D; Bendandi M; Moraleda J; Ribera JM; Albo C; Morales A; García JC; Fernández P; Cañigral G; Bergua J; Caballero MD;
Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891
[TBL] [Abstract][Full Text] [Related]
22. The aggressive peripheral T-cell lymphomas: 2015.
Armitage JO
Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
[TBL] [Abstract][Full Text] [Related]
23. Current state of art for transplantation paradigms in peripheral T-cell lymphomas.
Perrone G; Farina L; Corradini P
Expert Rev Hematol; 2013 Aug; 6(4):465-74. PubMed ID: 23991932
[TBL] [Abstract][Full Text] [Related]
24. Stem cell transplantation for peripheral T-cell lymphomas.
Jantunen E; D'Amore F
Leuk Lymphoma; 2004 Mar; 45(3):441-6. PubMed ID: 15160904
[TBL] [Abstract][Full Text] [Related]
25. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
[TBL] [Abstract][Full Text] [Related]
26. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study.
Feyler S; Prince HM; Pearce R; Towlson K; Nivison-Smith I; Schey S; Gibson J; Patton N; Bradstock K; Marks DI; Cook G
Bone Marrow Transplant; 2007 Sep; 40(5):443-50. PubMed ID: 17589529
[TBL] [Abstract][Full Text] [Related]
27. Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?
Casulo C; Horwitz S
Curr Oncol Rep; 2010 Nov; 12(6):374-82. PubMed ID: 20737300
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.
Paolo C; Lucia F; Anna D
Leuk Lymphoma; 2007 Aug; 48(8):1496-501. PubMed ID: 17701579
[TBL] [Abstract][Full Text] [Related]
29. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
Park SI; Horwitz SM; Foss FM; Pinter-Brown LC; Carson KR; Rosen ST; Pro B; Hsi ED; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Shustov AR;
Cancer; 2019 May; 125(9):1507-1517. PubMed ID: 30694529
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
Rogers AM; Brammer JE
Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group.
Numata A; Miyamoto T; Ohno Y; Kamimura T; Kamezaki K; Tanimoto T; Takase K; Henzan H; Kato K; Takenaka K; Fukuda T; Harada N; Nagafuji K; Teshima T; Akashi K; Harada M; Eto T;
Bone Marrow Transplant; 2010 Feb; 45(2):311-6. PubMed ID: 19597416
[TBL] [Abstract][Full Text] [Related]
32. Current treatment of peripheral T-cell lymphoma.
Horwitz SM; Coiffier B; Hsi ED; Pro B
Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 16):1-15. PubMed ID: 22361915
[TBL] [Abstract][Full Text] [Related]
33. Peripheral T-cell lymphoma: autologous hematopoietic cell transplantation as first-line therapy.
Laport GG
Curr Opin Oncol; 2010 Sep; 22(5):409-13. PubMed ID: 20683269
[TBL] [Abstract][Full Text] [Related]
34. Bone Marrow Transplantation for Peripheral T-Cell Non-Hodgkins' Lymphoma in First Remission.
Sharma M; Pro B
Curr Treat Options Oncol; 2015 Jul; 16(7):34. PubMed ID: 26076798
[TBL] [Abstract][Full Text] [Related]
35. Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.
Reimer P; Rüdiger T; Geissinger E; Weissinger F; Nerl C; Schmitz N; Engert A; Einsele H; Müller-Hermelink HK; Wilhelm M
J Clin Oncol; 2009 Jan; 27(1):106-13. PubMed ID: 19029417
[TBL] [Abstract][Full Text] [Related]
36. Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
Ahn JS; Yang DH; Jung SH; Chae YS; Sohn SK; Yhim HY; Kwak JY; Lee SR; Kim YK; Kim HJ; Lee JJ
Ann Hematol; 2013 Jun; 92(6):789-97. PubMed ID: 23358616
[TBL] [Abstract][Full Text] [Related]
37. Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
Sohn BS; Park I; Kim EK; Yoon DH; Lee SS; Kang BW; Jang G; Choi YH; Kim C; Lee DH; Kim S; Huh J; Suh C
Bone Marrow Transplant; 2009 Sep; 44(5):287-93. PubMed ID: 19234508
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapeutic advancements in peripheral T-cell lymphoma.
Reddy NM; Evens AM
Semin Hematol; 2014 Jan; 51(1):17-24. PubMed ID: 24468312
[TBL] [Abstract][Full Text] [Related]
39. Primary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas.
Gritti G; Boschini C; Rossi A; Delaini F; Grassi A; Algarotti A; Micò C; Trezzi R; Gianatti A; Barbui AM; Rambaldi A
PLoS One; 2015; 10(3):e0121822. PubMed ID: 25815886
[TBL] [Abstract][Full Text] [Related]
40. Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center.
Loirat M; Chevallier P; Leux C; Moreau A; Bossard C; Guillaume T; Gastinne T; Delaunay J; Blin N; Mahé B; Dubruille V; Augeul-Meunier K; Peterlin P; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Mohty M; Moreau P; Le Gouill S
Ann Oncol; 2015 Feb; 26(2):386-92. PubMed ID: 25392158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
